Alon Lazarus

Board Member at Auron Therapeutics

Dr. Alon Lazarus is a Biotech Investment Manager at Arkin Bio Ventures. Dr. Lazarus joined Arkin Holdings’ pharma division in 2013.

Prior to joining Arkin, Dr. Lazarus worked for the healthcare business development department of Yissum, the R&D arm of the Hebrew University of Jerusalem.

Dr. Lazarus holds a Ph.D in molecular biology and an MBA, both from the Hebrew University of Jerusalem.

Org chart

Eric Gomez

Board Observer

VR

Victoria Richon

Independent Board Member

Stéphane de Botton

Scientific Advisor

Thomas Graeber

Scientific Advisor

Isaac Ciechanover

Chairman

Mikhail Roshal

Scientific Advisor

Kimberly Stegmaier

Scientific Advisor

Shin-San Michael Su

Scientific Advisor

Teams

+7

Board of Directors

10 members

Timeline

  • Board Member

    Current role